Lou et al. [57] performed CRISPR functional genomics in KRAS-G12C-mutant lung cancer and pancreatic cancer cells and identified genes necessary for cancer cell survival when KRAS signaling is blocked by KRAS-G12C inhibitors, some of which have been termed “collateral dependencies” (CDs). The gene discussed is KRAS; the disease is pancreatic neoplasm.